$1.37
-0.06-4.2%
Last update: Nov 11, 7:30 AM
CervoMed Inc
CRVONASDAQ
The average analyst price target for CervoMed is $26.56, 1797.1% above the current price. Of 10 analysts, 10 rate it Buy. Targets range from $11 to $63. The latest change came on Aug 10, 2026, when Canaccord Genuity lowered its price target on CervoMed from $27 to $18 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 10 Analysts
Rating Trend — Last 9 Months
